Trial Profile
A multi-centre study to evaluate the effects of valsartan and the combination of valsartan and simvastatin on blood pressure (ambulatory and Std cuff) and on biochemical markers of endothelial function (hsCRP, MCP-1, serum F2 isprostanes, PAI-1, tPA, PICP, PIIINP, MMP9, MMP1, TIMP 1), safety and tolerability
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Valsartan (Primary)
- Indications Dyslipidaemias; Essential hypertension; Hypercholesterolaemia; Hyperlipidaemia; Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Novartis
- 17 Dec 2006 New trial record.